Department of Drug Administration(DDA) Drug Recall Notice
Department of Drug Administration(DDA) Drug Recall Notice
Based on the information received in Departmment of Drug Administartion (DDA), during the inspection monitoring, it was found that there was a labeling error in the medicine as per the details sold in the market. All stakeholders are advised not to use the drug and to immediately stop the sale and distribution of the drug and return it to the concerned supplier.
Product Name: Uzoline – 1000 (cefazolin for injectin USP 1000mg and sterilized water for injections BP 5 ml)
Name of Manufacturer and Address: Umedica Laboratories Pvt. Ltd. plot no: 221, G.I.D.C. Gujarat, India
Batch No. V30041
Mfg. Date: 05/2020
Exp Date: 04/2023
Reson Recall: Labelling Error
Recommend Post:
- DDA Notice Regarding Distribution of Tocilizumab Injection (Actemra) 400mg/20 ml
- List of Instant Hand Sanitizer Registered in DDA
- DDA Notice Regarding Recall of Handsanitizer
Discussion about this post